Medical Procedure News

RSS

HCRI completes enrollment in dual antiplatelet therapy clinical trial

The Harvard Clinical Research Institute (HCRI) announced today that the enrollment phase of the DAPT Study has been successfully completed. The DAPT Study is a four-year clinical trial investigating the duration of dual antiplatelet therapy (DAPT, the combination of aspirin and a thienopyridine/antiplatelet medication to reduce the risk of blood clots) following drug-eluting stent implantations.

27 Sep 2011

Patients with chronic conditions likely to change their preferences for CPR

Patients with chronic conditions are likely to change their preferences for receiving emergency procedures in the event of cardiac arrest, according to new findings.

27 Sep 2011

No link between chemotherapy during pregnancy and children's cognitive development

Children born after their mothers were treated with chemotherapy during pregnancy appear to be unaffected by the experience in terms of the development of their mental processes and the normal functioning of their hearts, according to new research presented at the 2011 European Multidisciplinary Cancer Congress.

27 Sep 2011

Scientists identify a way that chemotherapy causes platelet numbers to drop

Scientists at the Walter and Eliza Hall Institute have identified a way that chemotherapy causes platelet numbers to drop, answering in the process a decade-old question about the formation of platelets, tiny cells that allow blood to clot.

26 Sep 2011

Pacira announces data from EXPAREL clinical study presented at ASPS 2011 meeting

Pacira Pharmaceuticals, Inc. today announced that the company's lead investigational product for postsurgical pain management, EXPAREL, was highlighted in the "Hot Topics in Plastic Surgery" panel at the annual scientific assembly of the American Society of Plastic Surgeons (ASPS) in Denver, Colo.

26 Sep 2011

World's first treatment of metastasized brain cancer uses IsoRay's Cesium-131 brachytherapy seeds

IsoRay, a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, announced today that doctors at New York Presbyterian Hospital/ Weill Cornell Medical Center have performed the world's first treatment of metastasized brain cancer using IsoRay's Cesium-131 brachytherapy seeds.

26 Sep 2011

Study shows substantial differences in use of rectal cancer therapies across Europe

First results from an international comparison of the care of patients with rectal cancer have shown there are substantial differences in the use of chemotherapy and radiotherapy between European countries.

26 Sep 2011

Laurantis Pharma's Lymfactin rebuilds lymphatic vessels in pre-clinical animal models

Laurantis Pharma, a privately held biotechnology company based in Finland, today announced that Lymfactin, adenoviral VEGF-C growth factor therapy, was successful in rebuilding lymphatic vessels in pre-clinical animal models.

26 Sep 2011

Percutaneous hepatic perfusion extends survival time for melanoma patients

Melanoma of the eye frequently spreads to the liver and, once this has happened, there is no effective treatment and patients die within an average of two to four months. Only about one in ten patients live for a year. Now, final results from a phase III study have demonstrated that a new treatment significantly extends the time patients can live without the disease progressing.

26 Sep 2011

N.Y. State Department of Health releases 2010 report on hospital infection rates

For the third year in a row, Hospital for Special Surgery is the only hospital in New York State with an infection rate that is significantly lower than the state average for hip replacement or revision surgeries, according to the 2010 report on hospital infection rates just released by the State Department of Health.

26 Sep 2011

New research reveals how brain devotes time to reflect on tough choices

Take your time. Hold your horses. Sleep on it. When people must decide between arguably equal choices, they need time to deliberate. In the case of people undergoing deep brain stimulation (DBS) for Parkinson's disease, that process sometimes doesn't kick in, leading to impulsive behavior. New research into why that happens has led scientists to a detailed explanation of how the brain devotes time to reflect on tough choices.

26 Sep 2011

Gamma radiation could toughen up plastic prosthetic joints

A blast of gamma radiation could toughen up plastic prosthetic joints to make them strong enough to last for years, according to researchers in China writing in the current issue of the International Journal of Biomedical Engineering and Technology.

23 Sep 2011

Complications requiring hospitalization after prostate biopsy rise: Study

In a study of complication rates following prostate biopsy among Medicare beneficiaries, Johns Hopkins researchers have found a significant rise in serious complications requiring hospitalization.

23 Sep 2011

NYT: Ethics probe involves kidney transplant center, Rep. Berkley

In 2008 Ms. Berkley helped lead an effort to block a move by federal regulators to close Nevada's only kidney transplant center, which her husband's medical practice helps run under a $738,000-a-year contract. She also successfully pushed regulators, as recently as March, to reverse a plan to cut Medicare reimbursement to dialysis centers, including the dozen her husband's medical practice owns.

23 Sep 2011

SANUWAVE announces dermaPACE Phase III trial results on diabetic foot ulcers

SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today announced that the Company's dermaPACE device will be the subject of a presentation at Plastic Surgery 2011, the American Society of Plastic Surgeons' National Meeting being held September 23-27 in Denver.

23 Sep 2011

Researchers compare safety and effectiveness of cryotherapy, salicylic acid for verrucae

Research has shown no evidence of a difference in clearance rates between patient self-treatment and treatment given by healthcare professional for verrucae.

23 Sep 2011

STAAR's new Visian ICL with CentraFLOW technology showcased at ESCRS congress

STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced the Visian Implantable Collamer Lens (ICL), and new Visian ICL with CentraFLOW technology utilizing the KS-AquaPORT, were featured prominently in twice as many presentations at the 2011 Congress of European Society of Cataract and Refractive Surgeons (ESCRS) as those on the ICL during last year's Congress.

23 Sep 2011

Viable non-invasive, drug-free alternative to IVF for infertile couples

A new study published in European Obstetrics & Gynaecology shows that the DuoFertility monitor and service used for six months gives the same chance of pregnancy as a cycle of in-vitro fertilisation (IVF) for many infertile couples.

23 Sep 2011

Gynesonics initiates VizAblate FAST-EU study for uterine fibroid treatment

Gynesonics, Inc., a women's healthcare company focused on minimally invasive solutions for symptomatic uterine fibroids, today announced the start of, and initial treatments in, the FAST-EU Trial, a multicenter clinical study to demonstrate the effectiveness of the VizAblate® procedure for the treatment of uterine fibroids associated with heavy menstrual bleeding.

22 Sep 2011

Study: Fear of childbirth affects obstetric outcomes and increases elective C-sections

A new study published in the international journal Acta Obstetricia et Gynecologica Scandinavica (AOGS) reveals that fear of childbirth is a predisposing factor for emergency and elective cesarean sections, even after psychological counseling. This may mean a negative experience that lasts a lifetime among the approximately 3% of women who in this study were estimated to suffer from excessive fear of childbirth.

22 Sep 2011

Medical Procedure News

HCRI completes enrollment in dual antiplatelet therapy clinical trial

Patients with chronic conditions likely to change their preferences for CPR

No link between chemotherapy during pregnancy and children's cognitive development

Scientists identify a way that chemotherapy causes platelet numbers to drop

Pacira announces data from EXPAREL clinical study presented at ASPS 2011 meeting

World's first treatment of metastasized brain cancer uses IsoRay's Cesium-131 brachytherapy seeds

Study shows substantial differences in use of rectal cancer therapies across Europe

Laurantis Pharma's Lymfactin rebuilds lymphatic vessels in pre-clinical animal models

Percutaneous hepatic perfusion extends survival time for melanoma patients

N.Y. State Department of Health releases 2010 report on hospital infection rates

New research reveals how brain devotes time to reflect on tough choices

Gamma radiation could toughen up plastic prosthetic joints

Complications requiring hospitalization after prostate biopsy rise: Study

NYT: Ethics probe involves kidney transplant center, Rep. Berkley

SANUWAVE announces dermaPACE Phase III trial results on diabetic foot ulcers

Researchers compare safety and effectiveness of cryotherapy, salicylic acid for verrucae

STAAR's new Visian ICL with CentraFLOW technology showcased at ESCRS congress

Viable non-invasive, drug-free alternative to IVF for infertile couples

Gynesonics initiates VizAblate FAST-EU study for uterine fibroid treatment

Study: Fear of childbirth affects obstetric outcomes and increases elective C-sections

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Latest News